
    
      It is the first large-scale and systematic study that fully recognize and review on the
      mutation spectrum of BRCA1/2 and the risk of Breast cancer in Chinese high risk group, it
      will be a Landmark research of susceptibility genes in Chinese breast cancer.
    
  